High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.

Pyothorax-associated lymphoma (PAL) is a rare tumor associated with long-standing tuberculous pyothorax. Most of these lymphomas are B-cell lymphomas of high-grade malignancy. Over 50 cases have been reported in Japan, but no cases have been described in Western countries. Its pathogenesis remains unknown. We studied immunohistologically the expression of Epstein-Barr virus- (EBV) encoded latent gene products, EB nuclear antigen-2 and LMP-1, in four cases of PAL. Fifty B-cell lymphomas unrelated to pyothorax, and five EBV-bearing lymphoblastic tumors produced in severe combined immune deficient mice (severe combined immune deficient-EBV+ tumors) were also studied as controls. Marked expression of EB nuclear antigen-2 was demonstrated on all four PALs. LMP-1 was also present in all cases, but both the staining intensity and the number of stained cells remained less than on severe combined immune deficient-EBV+ tumors. Neither EB nuclear antigen-2 nor LMP-1 was observed in the 50 control B-cell lymphomas. Additional molecular genetic analysis revealed that EBVs are incorporated into each PAL clonally. These results confirm the definite association of EBV with PALs, although the significance of weak expression of LMP-1 awaits further study.

[1]  A. Rickinson,et al.  Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes , 1992, Journal of virology.

[2]  M. Gaffey,et al.  Association of Epstein-Barr virus with human neoplasia. , 1992, Pathology annual.

[3]  S. Hamilton-Dutoit,et al.  Expression of Epstein–Barr virus replicative proteins in aids‐related non‐Hodgkin's lymphoma cells , 1991, The Journal of pathology.

[4]  K. Aozasa,et al.  Prognostic factors for pleural lymphoma patients. , 1991, Japanese journal of clinical oncology.

[5]  L. Young,et al.  Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man , 1991, The Journal of experimental medicine.

[6]  G. Inghirami,et al.  Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. , 1990, The American journal of pathology.

[7]  E. Kieff,et al.  Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 , 1990, Journal of virology.

[8]  E. Kieff,et al.  A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1 , 1990, Journal of virology.

[9]  T. Kipps,et al.  EBV-associated B-cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency. , 1990, Current topics in microbiology and immunology.

[10]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Kieff,et al.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.

[12]  K. Aozasa,et al.  Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. , 1989, Japanese journal of clinical oncology.

[13]  D. Huang,et al.  Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. , 1988, The American journal of pathology.

[14]  James F. Jones,et al.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. , 1988, The New England journal of medicine.

[15]  K. Aozasa,et al.  Non‐Hodgkin's lymphoma of the pleural cavity developing from long‐standing pyothorax , 1987, Cancer.

[16]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[17]  E. Kieff,et al.  Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. , 1987, The Journal of general virology.

[18]  N. Raab-Traub,et al.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.

[19]  D. Saw,et al.  Malignant lymphoepithelial lesion of the salivary gland. , 1986, Human pathology.

[20]  D. Staunton,et al.  Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells , 1985, Journal of virology.

[21]  Robert Walgate,et al.  Proliferation , 1985, Nature.

[22]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  I. W. Mclean,et al.  PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.